Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|March 13, 2025
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative CasesSaubia Fathima, Maymona Abdelmagid, Ali Alsugair, et al.
JCI Insight|January 22, 2020
Arp2/3 inactivation causes intervertebral disc and cartilage degeneration with dysregulated TonEBP-mediated osmoadaptationSteven Tessier, Alexandra C Doolittle, Kimheak Sao, et al.
American Journal of Hematology|January 4, 2022
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitorsYazan Numan, Zaid Abdel Rahman, Justin Grenet, et al.
American Journal of Hematology|December 15, 2023
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survivalOmer Karrar, Maymona Abdelmagid, Masooma Rana, et al.
Nature Communications|November 9, 2019
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemiaLiping Dou, Fei Yan, Jiuxia Pang, et al.
Blood Neoplasia|March 27, 2026
Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trialJames M Foran, Zhuoxin Sun, Selina M Luger, et al.
American Journal of Hematology|December 10, 2023
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patientsNaseema Gangat, Omer Karrar, Moazah Iftikhar, et al.
Blood Advances|April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohortMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective StudyMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Pageof 18